Any current/future new fundraising through debt or equity?

The transcript on page 17 and surrounding pages does not mention any current or planned fundraising through debt or equity. The company focuses on organic growth, acquisitions, and improving margins rather than raising capital. Aneesh Reddy highlights consistent cash generation and strong operating cash flow, indicating no immediate need for external funding. Acquisition strategy is funded through internal resources and cash flows, as seen with recent deals like SessionM. No explicit commentary on upcoming equity or debt issuance was made during the call. Overall, Capillary Technologies appear

Any current/future capex/capital investment/strategic investment?

Capillary Technologies focuses on continued investment in technology, particularly in AI, with about 4-5% of revenues currently from AI-related products. They invest approximately INR10-20 million annually to keep their platform updated, adapting to technology waves like cloud, mobile, social, AI, and e-commerce. Recent acquisitions require upfront investment and time (18-24 months) to start delivering cash flow, followed by 2-3 years to pay off. They are investing in ramping up sales teams, especially in the US, contributing to cost growth. The company is expanding into broader marketing auto

Future growth expectations in sales/revenue/volumes?

Capillary targets about 115% Net Revenue Retention (NRR) on organic business, translating to roughly 10-11% growth from existing customers annually. New customer acquisitions are expected to contribute about 10% growth yearly, with new ACV around INR70-80 crores. Inorganic growth through acquisitions like SessionM adds significant revenue but takes 1-2 years to contribute fully to EBITDA margins. AI-driven products (AIRA stack) are emerging, currently contributing ~4-5% of revenue, with potential to increase NRR through outcome-based pricing and enhanced marketing automation. The company antic

Future growth expectations in earnings/operating earnings/profits/EPS?

Capillary Technologies expects steady revenue growth with about 10-11% coming from net retention rate (NRR) on organic business and around 10% growth from new customer acquisitions annually. EBITDA margins have shown improvement, with Q4 FY26 adjusted EBITDA margin at 19% and a full-year margin at 14.7%. Steady-state EBITDA margin target is about 25-30%, driven by high gross margins (~70%) and controlled operating costs. Acquisitions like SessionM initially show lower margins but are expected to achieve margin expansion within 1-2 years by migrating customers to Capillary’s platform. Margin e

Current/ Expected Orderbook/ Pending Orders?

As of the latest earnings call, Capillary Technologies mentioned an Annual Contract Value (ACV) of approximately INR120 crores signed up, but not all of it is fully live yet, indicating some order backlog to be realized in upcoming quarters (Q1 and Q2 FY27). The company highlighted a healthy run rate of INR765 crores in Annual Recurring Revenue (ARR) by end of FY26, reflecting the contracted business that contributes to future revenue. There is explicit mention of a large INR20 million contract announced last quarter, partially pending activation. Given the nature of long sales cycles wi

IN US

Sale is live|00:00:00left today

Capillary Technologies India LtdQ1 FY26IT - Software

Capillary Technologies India Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹508P/E: 141.2Market Cap: ₹4.2K CrSector: IT - Software

Management growth scorecard

Revenue

Category 2

Margin

Category 2

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→Capillary targets about 115% Net Revenue Retention (NRR) on organic business, translating to roughly 10-11% growth from existing customers annually.
→New customer acquisitions are expected to contribute about 10% growth yearly, with new ACV around INR70-80 crores.
→Inorganic growth through acquisitions like SessionM adds significant revenue but takes 1-2 years to contribute fully to EBITDA margins.
→AI-driven products (AIRA stack) are emerging, currently contributing ~4-5% of revenue, with potential to increase NRR through outcome-based pricing and enhanced marketing automation.
→The company anticipates a steady increase in gross margins, aiming for a 70% gross margin in the steady state.
→Continued investment in sales teams, especially in the US, supports ongoing market share expansion and revenue growth.
→Overall revenue growth guidance lies around a sustained 23% year-on-year, with solid new business momentum and margin expansion over time.

Margin guidance

Category 2

→Capillary Technologies expects steady revenue growth with about 10-11% coming from net retention rate (NRR) on organic business and around 10% growth from new customer acquisitions annually.
→EBITDA margins have shown improvement, with Q4 FY26 adjusted EBITDA margin at 19% and a full-year margin at 14.7%.
→Steady-state EBITDA margin target is about 25-30%, driven by high gross margins (~70%) and controlled operating costs.
→Acquisitions like SessionM initially show lower margins but are expected to achieve margin expansion within 1-2 years by migrating customers to Capillary’s platform.
→Margin expansion on organic business expected at 2-3% annually; overall margin growth may be tempered in near term due to integration of acquisitions.
→Earnings growth is supported by a combination of organic growth, margin improvements, and successful integration of acquisitions.
→Cash flow generation is strong, with free cash flow to PAT at 200%, signaling healthy earnings quality.

3 more insights locked — sign up free to unlock

Fundraise plans

→The transcript on page 17 and surrounding pages does not mention any current or planned fundraising through debt or equity.
→The company focuses on organic growth, acquisitions, and improving margins rather than raising capital.
→Aneesh Reddy highlights consistent cash generation and strong operating cash flow, indicating no immediate need for external funding.
→Acquisition strategy is funded through internal resources and cash flows, as seen with recent deals like SessionM.
→No explicit commentary on upcoming equity or debt issuance was made during the call.
→Overall, Capillary Technologies appears well-capitalized and focused on profitable growth without immediate plans for fundraising.

Order book

Yes

→As of the latest earnings call, Capillary Technologies mentioned an Annual Contract Value (ACV) of approximately INR120 crores signed up, but not all of it is fully live yet, indicating some order backlog to be realized in upcoming quarters (Q1 and Q2 FY27).
→The company highlighted a healthy run rate of INR765 crores in Annual Recurring Revenue (ARR) by end of FY26, reflecting the contracted business that contributes to future revenue.
→There is explicit mention of a large INR20 million contract announced last quarter, partially pending activation.
→Given the nature of long sales cycles with large enterprises, there is a natural delay between contract signing and revenue recognition.
→Overall, Capillary shows strong visibility and orderbook momentum supported by both organic growth and acquisitions (like SessionM), with expectation of this order inflow materializing steadily over the next few quarters.

Capex plans

Yes

→Capillary Technologies focuses on continued investment in technology, particularly in AI, with about 4-5% of revenues currently from AI-related products.
→They invest approximately INR10-20 million annually to keep their platform updated, adapting to technology waves like cloud, mobile, social, AI, and e-commerce.
→Recent acquisitions require upfront investment and time (18-24 months) to start delivering cash flow, followed by 2-3 years to pay off.
→They are investing in ramping up sales teams, especially in the US, contributing to cost growth.
→The company is expanding into broader marketing automation (Engage stack) and AI-powered intelligence/action capabilities (AIRA).
→No explicit mention of large new capital expenditures beyond acquisitions; focus remains on strategic M&A and technology enhancements integrated into their cloud platform.
→Continued investments are expected to drive steady-state margins of 25-30% EBITDA over time.

How does Capillary Technologies India Ltd rank vs peers in IT - Software?

Pro feature

1Capillary Technologies India Ltd

Rev 2Mar 2

See full IT - Software sector rankings

Want more stocks like Capillary Technologies India Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio